Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.EDAP TMS S.A. (FOCL) Presents at 2026 UBS Global Healthcare Conference Transcript
EDAP TMS S.A. (FOCL) Q3 2026 Earnings Call Transcript
FocalTherics Q3 Earnings Call Highlights
FocalTherics™ Reports Third Quarter 2026 Financial Results
FocalTherics™ to Participate in Upcoming Investor Conferences
FocalTherics™ to Announce Third Quarter 2026 Financial Results on November 5, 2026
FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Analysts Set FocalTherics (NASDAQ:FOCL) Target Price at $9.00
EDAP TMS S.A. (FOCL) Q2 2026 Earnings Call Transcript
FocalTherics Q2 Earnings Call Highlights
FocalTherics™ Reports Second Quarter 2026 Financial Results
FocalTherics™ Announces Pricing of Public Offering of American Depositary Shares
FocalTherics™ Reports Preliminary Financial Results for Second Quarter of 2026
FocalTherics™ Announces Proposed Public Offering of American Depositary Shares
FocalTherics (FOCL) Surges 6.2%: Is This an Indication of Further Gains?
FocalTherics™ to Announce Second Quarter 2026 Financial Results on August 13, 2026
FocalTherics™ to Announce Second Quarter 2026 Financial Results on August 13, 2026
FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients
FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients
FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical
Already premium?